VACCINES

Scientists see downsides to top COVID-19 vaccines from Russia, China

Scientists see downsides to top COVID-19 vaccines from Russia, China

Published 02/09/2020

(This August 31 story is refiled to add dropped word founding to Ertl’s title in paragraph 13) By Allison Martell and Julie Steenhuysen TORONTO/CHICAGO (Reuters) [more…]

Some Russian teachers fear back-to-school shots of ‘Sputnik V’ COVID vaccine

Some Russian teachers fear back-to-school shots of ‘Sputnik V’ COVID vaccine

Published 01/09/2020

MOSCOW (Reuters) - A small independent Russian teachers’ union is urging members not to be coerced into accepting shots of the “Sputnik V” coronavirus vaccine [more…]

Explainer: How common cold viruses are being used in vaccines from Russia, China

Explainer: How common cold viruses are being used in vaccines from Russia, China

Published 01/09/2020

(Reuters) - The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China’s CanSino Biologics (6185.HK) and Russia’s Gamaleya Institute have been studied for [more…]

Brazil’s Bolsonaro says nobody will be forced to have coronavirus vaccine

Brazil’s Bolsonaro says nobody will be forced to have coronavirus vaccine

Published 01/09/2020

BRASILIA (Reuters) - Brazilian President Jair Bolsonaro, who has consistently downplayed the severity of the coronavirus outbreak, said on Monday that nobody will be forced [more…]

AstraZeneca’s COVID-19 vaccine candidate begins late-stage U.S. study

AstraZeneca’s COVID-19 vaccine candidate begins late-stage U.S. study

Published 31/08/2020

(Reuters) - AstraZeneca Plc said on Monday it has begun enrolling adults for a U.S.-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate. [more…]

CABEI approves $400 million loan to Central American nations for vaccine

CABEI approves $400 million loan to Central American nations for vaccine

Published 31/08/2020

TEGUCIGALPA (Reuters) - The Central American Bank for Economic Integration (CABEI) has approved a $400 million loan to seven regional nations and the Dominican Republic [more…]

Britain encourages at-risk groups to sign up for COVID-19 vaccine trials

Britain encourages at-risk groups to sign up for COVID-19 vaccine trials

Published 17/08/2020

LONDON (Reuters) - Britain on Monday urged elderly people and volunteers from Black and Asian minority groups to sign up to a COVID-19 vaccine trial [more…]

Humanity versus disease showcased as London’s Science Museum reopens doors

Humanity versus disease showcased as London’s Science Museum reopens doors

Published 11/08/2020

LONDON (Reuters) - Exhibits showcasing humanity’s battle with infectious disease will greet visitors recently emerged from coronavirus lockdowns when London’s Science Museum re-opens its doors [more…]

SAP picked by Moderna to help distribute COVID-19 vaccine candidate

SAP picked by Moderna to help distribute COVID-19 vaccine candidate

Published 27/07/2020

BERLIN (Reuters) - Business software group SAP (SAPG.DE) has been selected by Moderna (MRNA.O) to help distribute the potential COVID-19 vaccine that the U.S. pharmaceuticals [more…]

Emergent signs $174 million deal to make AstraZeneca’s potential COVID-19 vaccine

Emergent signs $174 million deal to make AstraZeneca’s potential COVID-19 vaccine

Published 27/07/2020

(Reuters) - Emergent BioSolutions Inc said on Monday it signed a $174 million agreement with AstraZeneca to develop and manufacture the British drugmaker’s COVID-19 vaccine [more…]